NCT04057157View on ClinicalTrials.gov

Post-market Assessment of Biodesign Dural Repair Grafts

CompletedOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

June 6, 2022

Study Completion Date

September 15, 2022

Conditions
Cerebrospinal Fluid Leak
Interventions
DEVICE

Biodesign Dural or Duraplasty Repair Grafts

Patients will receive the Biodesign Dural or Duraplasty Repair Grafts according to the Instruction for Use.

Trial Locations (3)

35294

University of Alabama Birmingham Hospital, Birmingham

40139

Ospedale Bellaria-Bolonga, Bologna

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY

NCT04057157 - Post-market Assessment of Biodesign Dural Repair Grafts | Biotech Hunter | Biotech Hunter